Clinical Trial Update: Sildenafil for the Prevention of Right Heart Failure Following LVAD Implantation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating sildenafil to prevent right heart failure after LVAD implantation is reported but status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Heart Failure
• Right Heart Failure

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University of Calgary | Conditions: End Stage Heart Failure | Phase 3 | Status: UNKNOWN